VitaDAO funds longevity research through a blockchain-based decentralized autonomous organization (DAO), showcasing the potential of collaborative, transparent and alternative systems while also highlighting the challenges of coordination, regulation, biases and skepticism in reshaping traditional research financing methods.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
Most materials are publicly available on VitaDAO Discourse (https://gov.vitadao.com/) or Discord (https://discord.com/invite/3S3ftnmZYD). Interviews are under NDAs.
References
Grassi, L. & Fantaccini, S. Financ. Innov. 8, 84 (2022).
Seyhan, A. A. Transl. Med. Commun. 4, 18 (2019).
Goldberg, M. & Schär, F. J. Bus. Res. 160, 113764 (2023).
Santana, C. & Albareda, L. Technol. Forecast. Soc. Change 182, 121806 (2022).
Buterin, V. A next-generation smart contract and decentralized application platform. https://ethereum.org/content/whitepaper/whitepaper-pdf/Ethereum_Whitepaper_-_Buterin_2014.pdf (2014).
Wang, S. et al. IEEE Trans. Comput. Soc. Syst. 6, 870–878 (2019).
Singh, M. & Kim, S. Adv. Comput. 115, 115–140 (2019).
Kaal, W. A. Ann. Corp. Gov. 5, 237–307 (2021).
Faqir-Rhazoui, Y., Arroyo, J. & Hassan, S. J. Internet Serv. Appl. 12, 9 (2021).
Zhao, X., Ai, P., Lai, F., Luo, X. & Benitez, J. J. Oper. Manage. 68, 649–674 (2022).
Grassi, L., Lanfranchi, D., Faes, A. & Renga, F. M. Qual. Res. Account. Manag. 19, 323–347 (2022).
Murray, A., Kuban, S., Josefy, M. & Anderson, J. Acad. Manage. Perspect. 35, 622–641 (2021).
DeFrancesco, L. & Klevecz, A. Nat. Biotechnol. 40, 1310–1315 (2022).
Bellavitis, C., Fisch, C. & Momtaz, P. P. Ventur. Cap. 25, 187–203 (2023).
Onjewu, A. K., Walton, N. & Koliousis, I. Technol. Forecast. Soc. Change 191, 122482 (2023).
Bischof, E. et al. IEEE Access 10, 33048–33058 (2022).
Beck, R., Müller-Bloch, C. & King, J. L. J. Assoc. Inf. Syst. 19, 1020–1034 (2018).
Saurabh, K., Rani, N. & Upadhyay, P. Benchmarking (Bradf.) 30, 475–502 (2023).
Zamani, E. D. & Giaglis, G. M. Ind. Manage. Data Syst. 118, 637–652 (2018).
Ding, W. et al. IEEE Trans. Comput. Soc. Syst. 9, 1563–1573 (2022).
Gompers, P. A., Gornall, W., Kaplan, S. N. & Strebulaev, I. A. J. Financ. Econ. 135, 169–190 (2020).
Hsieh, Y. Y., Vergne, J. P., Anderson, P., Lakhani, K. & Reitzig, M. J. Organiz. Des. 7, 14 (2018).
Hassan, S. & De Filippi, P. Internet Policy Rev. https://doi.org/10.14763/2021.2.1556 (2021).
Acknowledgements
The authors wish to extend their profound gratitude to all interviewees from VitaDAO, who generously shared their insights and experiences, contributing immensely to the depth of our study. We would also like to recognize Scott Howell for his invaluable contributions to the development of the research design and overarching methodology. We also appreciate the engagement of one representative of Pfizer in this project. His participation and support have been pivotal in advancing this research.
Author information
Authors and Affiliations
Contributions
All authors were equally involved throughout the paper.
Corresponding author
Ethics declarations
Competing interests
To enter the DAO, on 1 November 2022, A.R. bought ten VitaDAO tokens — known as VITAs — which, at the time of purchase, were worth around $12 in total. Ten VITA tokens represent 0.000072% of voting rights at the date of the purchase and represents the minimum threshold to obtain full access to the DAO community and governance. Since the end of 2023, after completion of the study reported here, S.F. has served on the advisory board of VitaDAO, an organization that operates within the scope of the decentralized science movement. His role with VitaDAO is ongoing. Additionally, in 2023, subsequent to the study’s completion, he became an active participant in the decentralized science movement and has been involved in the establishment of a new DAO named Synapse. As of yet, Synapse is in its formative stage and is not yet operational.
Peer review
Peer review information
Nature Biotechnology thanks the anonymous reviewers for their contribution to the peer review of this work.
Rights and permissions
About this article
Cite this article
Fantaccini, S., Grassi, L. & Rampoldi, A. The potential of DAOs for funding and collaborative development in the life sciences. Nat Biotechnol 42, 555–562 (2024). https://doi.org/10.1038/s41587-024-02189-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-024-02189-0